Sg3 Management, LLC Reata Pharmaceuticals Inc Put Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$20.71 - $36.5 $1.76 Million - $3.1 Million
-85,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$24.12 - $39.6 $2.05 Million - $3.37 Million
85,000 New
85,000 $2.79 Million
Q3 2021

Nov 15, 2021
SELL
$100.0 - $143.02 $600,000 - $858,120
-6,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$78.27 - $151.29 $469,620 - $907,740
6,000 New
6,000 $849,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email